✦ LIBER ✦

A re-assessment of the role of combined androgen blockade for advanced prostate cancer

✍ Scribed by L. Klotz; P. Schellhammer; K. Carroll

Book ID: 109051160
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 126 KB
Volume: 93
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2004.04803.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twenty years of controversy surrounding

Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer

✍ Judd W. Moul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

The current issue of __Cancer__ includes a report on a concise, randomized controlled trial (RCT) with long‐term follow‐up that favors combined androgen blockade with bicalutamide versus lutenizing hormone‐releasing hormone monotherapy in Japanese men with locally advanced and metastatic prostate ca

Combined androgen blockade in the manage

Combined androgen blockade in the management of advanced prostate cancer: A sensible or ostensible approach

✍ MOHD S. ANSARI; NARMADA P. GUPTA; ASHOK K. HEMAL; PREM N. DOGRA; AMLESH SETH 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Combined androgen blockade for prostate

Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost-effectiveness

✍ Hideyuki Akaza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Combined androgen blockade with bicaluta

Combined androgen blockade with bicalutamide for advanced prostate cancer : Long-Term Follow-Up of a Phase 3, Double-Blind, Randomized Study for Survival

✍ Hideyuki Akaza; Shiro Hinotsu; Michiyuki Usami; Yoichi Arai; Hiroshi Kanetake; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

Systematic review and meta-analysis of m

Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma

✍ David J. Samson; Jerome Seidenfeld; Brian Schmitt; Vic Hasselblad; Peter C. Albe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND The current systematic review and meta‐analysis compared monotherapy and combined androgen blockade in the treatment of men with advanced prostate carcinoma. Outcomes of interest included overall, cancer specific, and progression‐free survival; time to treatment failure;

Development of anemia and recovery in pr

Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy

✍ Asbell, S. O.; Leon, S. A.; Tester, W. J.; Brereton, H. D.; Ago, C. T.; Rotman, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

## BACKGROUND. The objective of this study was to document previously unreported anemia in prostate cancer patients treated with neoadjuvant combined androgen blockade (CAB) and pelvic radiotherapy (XRT). METHODS. Four institutions treated 141 patients (mean age f SD, 70.9 ? 6.5 years) with zolad